TAWANA COOPER: Open Payments
NPI 1487656641 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 23 payments from 11 companies in 2025. Trend: 2023 $803 · 2024 $1,391 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $249 |
| Ardelyx, Inc. | 4 | $201 |
| AKEBIA THERAPEUTICS INC | 1 | $96 |
| KYOWA KIRIN, INC. | 1 | $80 |
| Lilly USA, LLC | 2 | $40 |
| Ascendis Pharma Endocrinology Inc | 2 | $36 |
| Vifor Pharma, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Fresenius USA Marketing, Inc. | 1 | $22 |
Products named: Vanrafia, XPHOZAH 30 MG, Vafseo, IBSRELA, JARDIANCE, Yorvipath, Veltassa, TAVNEOS.
Industry payments across FL — which companies pay providers there.
